Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications

Functional Consequences of Neuromyelitis Optica-IgG Astrocyte Interactions on Blood-Brain Barrier Permeability and Granulocyte Recruitment

(2014) T. Vincent et al.   JOURNAL OF IMMUNOLOGY

Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury

(2010) Romain Marignier et al.   BRAIN

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice

(2010) Samira Saadoun et al.   BRAIN

EFNS guidelines on diagnosis and management of neuromyelitis optica

(2010) J. Sellner et al.   EUROPEAN JOURNAL OF NEUROLOGY

Autoimmune Channelopathies: Well-Established and Emerging Immunotherapy-Responsive Diseases of the Peripheral and Central Nervous Systems

(2010) Angela Vincent   JOURNAL OF CLINICAL IMMUNOLOGY

Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity

(2010) Harleen Saini et al.   JOURNAL OF NEUROIMMUNOLOGY

Neuromyelitis optica in France: A multicenter study of 125 patients

(2010) N. Collongues et al.   NEUROLOGY

B-CELL ACTIVATING FACTOR OF THE TNF FAMILY IS UPREGULATED IN NEUROMYELITIS OPTICA

(2010) K. Okada et al.   NEUROLOGY

Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo

(2009) Monika Bradl et al.   ANNALS OF NEUROLOGY

Intrathecal pathogenic anti–aquaporin-4 antibodies in early neuromyelitis optica

(2009) Jeffrey L. Bennett et al.   ANNALS OF NEUROLOGY

Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies

(2009) Grazia Paola Nicchia et al.   GLIA

Evidences for a Leaky Scanning Mechanism for the Synthesis of the Shorter M23 Protein Isoform of Aquaporin-4

(2009) Andrea Rossi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study

(2009) Lidia Sabater et al.   JOURNAL OF NEUROIMMUNOLOGY

Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis

(2009) A Petzold et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Prevention of orthogonal array of particles formation as a treatment approach for neuromyelitis optica

(2009) Arne Warth   MEDICAL HYPOTHESES

Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis

(2009) K. Yanagawa et al.   NEUROLOGY

Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum

(2009) Makoto Kinoshita et al.   NEUROREPORT

Treatment of Neuromyelitis Optica With Rituximab

(2008)   ARCHIVES OF NEUROLOGY

Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis

(2008) Patrick Waters et al.   ARCHIVES OF NEUROLOGY

Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study

(2008) Mark C. Genovese et al.   ARTHRITIS AND RHEUMATISM

Formation of aquaporin-4 arrays is inhibited by palmitoylation of N-terminal cysteine residues

(2008) Hiroshi Suzuki et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

(2008) S. Jarius et al.   BRAIN

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model

(2008) Susan K. Halstead et al.   BRAIN

Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity

(2008) M. Krumbholz et al.   BRAIN

Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis

(2008) Alexandre S. Basso et al.   JOURNAL OF CLINICAL INVESTIGATION

Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2

(2008) Shannon R. Hinson et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis

(2008) Paraskevi Zisimopoulou et al.   JOURNAL OF NEUROIMMUNOLOGY

Hypocretinergic dysfunction in neuromyelitis optica with coma-like episodes

(2008) B Carlander et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations

(2008) T Takahashi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica

(2008) B Weinstock-Guttman et al.   Multiple Sclerosis Journal

NMO-IgG and Devic's neuromyelitis optica: a French experience

(2008) Romain Marignier et al.   Multiple Sclerosis Journal

Seronegative neuromyelitis optica: improvement following lymphocytapheresis treatment

(2008) E Moreh et al.   Multiple Sclerosis Journal

RELAPSING INFLAMMATORY OPTICNEURITIS: IS IT NEUROMYELITIS OPTICA?

(2008) J. de Seze et al.   NEUROLOGY

NMO-IgG predicts the outcome of recurrent optic neuritis

(2008) M. Matiello et al.   NEUROLOGY

Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord

(2008) G.-Y. Xu et al.   NEUROSCIENCE

Échec thérapeutique du rituximab dans un cas de neuromyélite optique rémittente : suivi prospectif longitudinal sur deux ans

(2008) C. Cassinotto et al.   REVUE NEUROLOGIQUE

B cells as therapeutic targets in autoimmune neurological disorders

(2008) Marinos C Dalakas   Nature clinical practice. Neurology